Since the cell adhesion molecule CD44 has been linked in different cancer stem cells such as breast, liver, ovarian, pancreatic and prostate cancers [29], we next evaluated CD44 expression status by flow cytometry. This evidence concerns the gene CD44 and prostate carcinoma.